HNF1A and diabetes mellitus: As a consequence of these data, we now recommend that a sulfonylurea should be added to existing treatment, rather than replacing it, in individuals with HNF1A/HNF4A-MODY with a longer diabetes duration (>11 years), especially in those with higher HbA1c levels at genetic diagnosis and a BMI >25 kg/m2.